Digital therapeutics company Kaia Health is partnering with Italian pharma firm Chiesi Group to commercialize its chronic obstructive pulmonary disease (COPD) rehabilitation app in...
Biofourmis, which combines AI-based data analytics and biosensors to monitor the progress of medical treatments, has raised $100 million Series C financing round led...
US-based digital therapeutics company Biofourmis has signed an agreement to buy Zurich, Switzerland-based wearable biosensor company Biovotion. The deal consists of all Biovotion’s assets,...